TAK-063, a phosphodiesterase 10A inhibitor, modulates neuronal activity in various brain regions in phMRI and EEG studies with and without ketamine challenge. (2016)
Attributed to:
MRC Centre for Neurodevelopmental Disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.neuroscience.2016.10.006
PubMed Identifier: 27725212
Publication URI: http://europepmc.org/abstract/MED/27725212
Type: Journal Article/Review
Volume: 339
Parent Publication: Neuroscience
ISSN: 0306-4522